TeloYears

Telomere Diagnostics, Inc. (TDx), founded in 2010, is dedicated to leveraging the predictive power of telomere science to assess health status, disease risk, and responses to specific therapies. TDx's team of expert academic and industrial leaders are applying this Nobel Prize-winning science to market diagnostic and health monitoring tools that will universally benefit human health. TDx was founded by a team of telomere, genomics, and clinical experts whose discoveries founded and remain at the forefront of telomere science, including the 2009 Nobel Laureate in Medicine, and Drs. Calvin Harley, Elissa Epel, and Jue Lin.